دورية أكاديمية
Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study
| العنوان: | Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study |
|---|---|
| المؤلفون: | Linda A. Liang, Sylke R. Zeissig, Gunther Schauberger, Sophie Merzweiler, Kathrin Radde, Sabine Fischbeck, Hans Ikenberg, Maria Blettner, Stefanie J. Klug |
| المصدر: | BMC Women's Health, Vol 22, Iss 1, Pp 1-13 (2022) |
| بيانات النشر: | BMC, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Gynecology and obstetrics LCC:Public aspects of medicine |
| مصطلحات موضوعية: | Colposcopy, Non-attendance, Screening follow-up, Abnormal screening result, Cervical cancer screening, HPV status, Gynecology and obstetrics, RG1-991, Public aspects of medicine, RA1-1270 |
| الوصف: | Abstract Background A considerable proportion of cervical cancer diagnoses in high-income countries are due to lack of timely follow-up of an abnormal screening result. We estimated colposcopy non-attendance, examined the potential factors associated and described non-attendance reasons in a population-based screening study. Methods Data from the MARZY prospective cohort study were analysed. Co-test screen-positive women (atypical squamous cells of undetermined significance or worse [ASC-US+] or high-risk human papillomavirus [hrHPV] positive) aged 30 to 65 years were referred to colposcopy within two screening rounds (3-year interval). Women were surveyed for sociodemographic, HPV-related and other data, and interviewed for non-attendance reasons. Logistic regression was used to examine potential associations with colposcopy attendance. Results At baseline, 2,627 women were screened (screen-positive = 8.7%), and 2,093 again at follow-up (screen-positive = 5.1%; median 2.7 years later). All screen-positives were referred to colposcopy, however 28.9% did not attend despite active recall. Among co-test positives (ASC-US+ and hrHPV) and only hrHPV positives, 19.6% were non-attendees. Half of only ASC-US+ screenees attended colposcopy. Middle age (adjusted odds ratio [aOR] = 1.55, 95% CI 1.02, 4.96) and hrHPV positive result (aOR = 3.04, 95% CI 1.49, 7.22) were associated with attendance. Non-attendance was associated with having ≥ 3 children (aOR = 0.32, 95% CI 0.10, 0.86). Major reasons for non-attendance were lack of time, barriers such as travel time, need for childcare arrangements and the advice against colposcopy given by the gynaecologist who conducted screening. Conclusions Follow-up rates of abnormal screening results needs improvement. A systematic recall system integrating enhanced communication and addressing follow-up barriers may improve screening effectiveness. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1472-6874 |
| العلاقة: | https://doaj.org/toc/1472-6874Test |
| DOI: | 10.1186/s12905-022-01851-6 |
| الوصول الحر: | https://doaj.org/article/33679fc8290c47d1acf7c126d05a368bTest |
| رقم الانضمام: | edsdoj.33679fc8290c47d1acf7c126d05a368b |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 14726874 |
|---|---|
| DOI: | 10.1186/s12905-022-01851-6 |